Table 2 Univariate analysis of clinical variables for SUVmax of FDG-PET
Clinical factors | Total | FDG-PET(SUVmax) | Univariate analysis | |||
|---|---|---|---|---|---|---|
Low < 9.5 | (%) | High ≥ 9.5 | (%) | P value | ||
Total | 72 | 44 | (61) | 28 | (39) | |
FDG (SUVmax) mean | 5.52 | 13.37 | ||||
Age | ||||||
< 70 | 30 | 20 | (67) | 10 | (33) | 0.47 |
≥ 70 | 42 | 24 | (57) | 18 | (43) | |
Sex | ||||||
Male | 32 | 20 | (63) | 12 | (37) | 1.00 |
Female | 40 | 24 | (60) | 16 | (40) | |
Primary site | ||||||
Tongue | 41 | 26 | (63) | 15 | (37) | 0.81 |
Other | 31 | 18 | (58) | 13 | (42) | |
cT | ||||||
T1 | 16 | 12 | (75) | 4 | (25) | < 0.001 |
T2 | 32 | 26 | (81) | 6 | (19) | |
T3 | 10 | 4 | (40) | 6 | (60) | |
T4 | 14 | 2 | (14) | 12 | (86) | |
cStage | ||||||
I/II | 44 | 35 | (80) | 9 | (20) | < 0.001 |
III/IV | 28 | 9 | (32) | 19 | (68) | |